Atlas Trials

Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above

Clinical trial NCT07481604 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07481604
Sponsor
Aribio Lab Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Herpes Zoster
Start date
2026-04-01
Primary completion
2027-01-01
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.